Related Experiment Video
Updated: May 21, 2026

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
Published on: September 11, 2011
Pediatric devices and adverse events from A to Z: understanding the benefits and risks from a US FDA perspective
Joy Samuels-Reid1, Brenda Lawrence, Courtney Millin
1Division of Anesthesiology, General Hospital, Infection Control and Dental Devices, Office of Device Evaluation, Center for Devices and Radiological Health, US FDA, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA. joy.samuels-reid@fda.hhs.gov
Abstract:
Medical devices are often overlooked as a contributor to adverse events. In clinical practice, physicians are aware of the potential for adverse effects from drug products, which are routinely included in differential diagnoses of patients' presenting complaints. However, physicians may not always consider that the use, misuse or malfunction of a medical device, and/or its components, may result in a patient's presenting signs and symptoms or lack of improvement. Consideration of medical devices is particularly important in the pediatric population, who may be especially susceptible to device-related adverse events due to their smaller body size, weight and ongoing rapid growth and development.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Regulation
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmaceutical Poisoning: Potential Scenarios
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions